MARKET

MBIO

MBIO

Mustang Bio
NASDAQ
1.112
+0.002
+0.20%
Opening 09:51 01/06 EST
OPEN
1.120
PREV CLOSE
1.110
HIGH
1.120
LOW
1.092
VOLUME
3.43K
TURNOVER
--
52 WEEK HIGH
13.29
52 WEEK LOW
0.8926
MARKET CAP
8.12M
P/E (TTM)
-0.8833
1D
5D
1M
3M
1Y
5Y
1D
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga · 7h ago
Weekly Report: what happened at MBIO last week (1229-0102)?
Weekly Report · 1d ago
Mustang Bio Director Neil Herskowitz Reports Disposal of Common Shares
Reuters · 12/30/2025 21:18
Mustang Bio Director David Jin Reports Acquisition of Common Shares
Reuters · 12/30/2025 21:15
Weekly Report: what happened at MBIO last week (1222-1226)?
Weekly Report · 12/29/2025 09:30
Mustang Bio Shareholders Approve Equity Plans and Directors
TipRanks · 12/23/2025 21:45
Mustang Bio Inc. held annual shareholder meeting
Reuters · 12/23/2025 21:06
Weekly Report: what happened at MBIO last week (1215-1219)?
Weekly Report · 12/22/2025 09:30
More
About MBIO
Mustang Bio, Inc. is a clinical-stage biopharmaceutical company focused on translating medical breakthroughs into potential cures for cancers and autoimmune diseases. The Company has partnered with medical institutions to advance the development of chimeric antigen receptor modified T cell (CAR T) therapies. Its pipeline is focused in two core areas: CAR T therapies for autoimmune diseases and hematologic malignancies and CAR T therapies for solid tumors. It is developing a CAR T therapy for hematologic malignancies and autoimmune diseases in partnership with Fred Hutchinson Cancer Center targeting CD20 and for solid tumors in partnership with City of Hope National Medical Center targeting IL13Ra2. It has also partnered with Nationwide Children’s Hospital for a herpes simplex virus type 1 oncolytic virus to enhance the activity of MB-101 for the treatment of patients with high-grade malignant brain tumors.

Webull offers Mustang Bio Inc stock information, including NASDAQ: MBIO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MBIO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MBIO stock methods without spending real money on the virtual paper trading platform.